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Available online 25 March 2008Mitochondrial involvement in yeast apoptosis is probably the most unifying feature in the ﬁeld. Reports
proposing a role for mitochondria in yeast apoptosis present evidence ranging from the simple observation of
ROS accumulation in the cell to the identiﬁcation of mitochondrial proteins mediating cell death. Although
yeast is unarguably a simple model it reveals an elaborate regulation of the death process involving distinct
proteins and most likely different pathways, depending on the insult, growth conditions and cell metabolism.
This complexity may be due to the interplay between the death pathways and the major signalling routes in
the cell, contributing to a whole integrated response. The elucidation of these pathways in yeast has been a
valuable help in understanding the intricate mechanisms of cell death in higher eukaryotes, and of severe
human diseases associated with mitochondria-dependent apoptosis. In addition, the absence of obvious
orthologues of mammalian apoptotic regulators, namely of the Bcl-2 family, favours the use of yeast to assess
the function of such proteins. In conclusion, yeast with its distinctive ability to survive without respiration-
competent mitochondria is a powerful model to study the involvement of mitochondria and mitochondria
interacting proteins in cell death.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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Yeast apoptosis is a quite new research ﬁeld which established this
unicellular eukaryotic organism as a model system to highlight
molecular mechanisms of apoptotic pathways, and offered new
insights into human diseases involving mitochondria-dependent
apoptotic mechanisms. Of special interest to the ﬁeld was the early
recognition in yeast of a mitochondria-mediated apoptotic pathway
showing similarities to the mammalian intrinsic pathway. This feature
together with the genetic tractability of yeast and easy manipulation
of mitochondrial respiration, either by changing growth conditions or
by the loss of mitochondrial DNA, prompt to an increased interest in
exploring this simple model to unveil unknown facets of the role of
mitochondria in cell death execution. Hitherto, different alterations in
mitochondrial structure and function during yeast apoptosis have
been identiﬁed. These changes include a transient mitochondrial
hyperpolarization, production of reactive oxygen species (ROS),
depolarization, release of cytochrome c (cyt c), yeast apoptosis
inducing factor (Aif1p) and yeast endonuclease G (Nuc1p), as well as
reduction in cristae number, mitochondrial swelling, mitochondrial
fragmentation and degradation. The involvement of yeast orthologues
of some of the mammalian permeability transition pore (PTP)
components in mitochondria permeabilization and cyt c release, inrtamento de Biologia, Campus
314; fax: +351 253678980.
-Real).
l rights reserved.the absence of heterologous expression of Bcl-2 family members, has
been ascertained.
The aim of this work is to provide a comprehensive and up-to-date
review on mitochondria-dependent apoptosis in yeast while identify-
ing some unanswered questions and gaps in the understanding of this
subject. The ﬁrst part of this review lists the apoptotic inducers which
target mitochondria and describes the mitochondrial dysfunctions
reported in response to those triggers. In the second part, some
identiﬁed signalling pathways upstreammitochondria, as well as their
crosstalk with other yeast signalling cascades are described. The third
part describes the mitochondrial proteins involved in apoptosis regu-
lation. The fourth part focuses on the proposedmechanisms underlying
mitochondrial membrane permeabilization, mitochondria network
fragmentation and on proteins released from mitochondria. The ﬁnal
part covers the yeast mitochondria-dependent apoptotic pathways
which revealed responsiveness to the heterologous expression of
mammalian apoptotic regulators or of different apoptotic proteins.
2. Stimuli causing mitochondria-dependent apoptosis and
associated mitochondrial dysfunctions
Although different compounds, gene alterations and physiological
conditionswere shown to induce apoptosis in the yeast Saccharomyces
cerevisiae, clear mitochondrial involvement has only been shown for
a few apoptotic scenarios (Table 1). Several studies show indirect
evidences ofmitochondrial involvement based on the assessmentof an
increase in ROS production. This was the case for apoptosis induced by
amino acid starvation [1], valproic acid [2], jasplakinolide [3] or in
Table 1
Compounds, gene alterations and physiological conditions that induce mitochondria-associated apoptosis in Saccharomyces cerevisiae
Trigger Effects on mitochondria Additional evidences of mitochondrial involvement References
Compound
Acetic acid Translocation of cyt c to the cytosol atp10Δ no cyt c release [8]
ROS production (Mitotracker Red) atp10Δ, cyc3Δ and rho0 more resistant
Decreased COX II
Decreased respiration
Decreased amount cyt a+a3
Initial hyperpolarization followed by depolarization
nuc1Δ more resistant in glycerol grown cells [10]
tim18 Δ more resistant [198]
Mitochondrial fragmentation ﬁs1Δ more sensitive, and dnm1Δ and mdv1Δ more resistant [9]
aif1Δ more resistant [11]
ysp2Δ more resistant [37]
por1Δ more sensitive and aac1Δ/aac2/Δaac3Δ more
resistant
[12]
Amiodarone ROS production at Complex III ysp1Δ more resistant [13]
Up-regulation of mitochondrial activity
Cyt c release
Increased ΔΨm
ysp2Δ more resistant [37]
Arsenite ROS production (DHR123) Rho0 more resistant [19]
Decreased ΔΨm
tim18 Δ more resistant [198]
Diamide ROS production (Mitotracker Red) por1Δ more sensitive [12]
aac1Δ/aac2/Δaac3Δ more resistant
Edelfosine ROS production (NBT-cytoﬂuorimetric) Rotenone and α-tocopherol inhibited [20]
Decreased ΔΨm ROS production and apoptosis
Ethanol ROS production (H2DCF-DA) ﬁs1Δ more sensitive [24]
Mitochondrial fragmentation
Glucose (in the absence of additional nutrients) ROS production (H2DCF-DA) Induction of petites [18]
High glucose or sorbitol (hyperosmotic stress) Mitochondrial swelling and reduction of cristae
number
cyc1Δcyc7Δ and cyc3Δ more resistant [22]
ROS production (DE, H2DCFDA).
tim18 Δ more resistant [198]
H2O2 ﬁs1Δ more sensitive [9]
aif1Δ more resistant [11]
Mitochondrial fragmentation [57]
Down expression of peroxiredoxin II and GST I [199]
Cyt c release [12]
mmi1Δ more resistant [50]
tim18 Δ more resistant [198]
Jasplakinolide (reduced actin dynamics) ROS production (H2DCF-DA) [3]
Pheromone ROS production (H2DCF-DA) Rho0 suppress apoptosis and ROS production [23]
cyc1Δcyc7Δ more resistant
ROS production (H2DCF-DA) ysp1Δ more resistant [13]
Increased ΔΨm
Valproic acid ROS production (DE) [2]
Change in a gene
act1-195 ROS production (H2DCF-DA) Rho0 prevented ROS accumulation [3]
Reduced actin dynamics Reduced ΔΨm
asf1/cia1Δ Decreased ΔΨm [14]
Histone chaperone Cyt c release
Dysfunction of mitochondrial H+-pump
cdc13Δ ROS production (DHR 123) Rho0 suppress apoptosis [16]
Abnormal telomeres, exposed G-tails Mitochondrial proteins involved in COX regulation
suppress apoptosis
Cdc48S565G ROS production (DHR 123) [141]
Altered vesicular fusion Respiratory deﬁciency Rho0 suppress sensitivity [15]
Cyt c accumulation in the cytosol
Mitochondrial enlargement
Proteomic alteration in the mitochondria
Inhibition of ROS production by
complex III inhibitors
end3Δ ROS production (H2DCF-DA) Rho0 and antimycin prevented ROS accumulation [42]
Reduced actin dynamics Decreased ΔΨm
Overexpression of sla1Δ118−511 ROS production (H2DCF-DA) Rho0 and antimycin prevented ROS accumulation [42]
Reduced actin dynamics Decreased ΔΨm
Overexpression of NDI1 (orthologue of AMID) ROS production in mitochondria sod2Δ more sensitive [17]
Reduced ΔΨm Acquired resistance by deletion of genes coding for
proteins from electron transport chain
orc2-1 ROS production (H2DCFDA) [4]
Defects in initiation of replication
(continued on next page)
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Table 1 (continued)
Trigger Effects on mitochondria Additional evidences of mitochondrial involvement References
Change in a gene
pds5-1 ROS production (DHR 123) [5]
Defects in maintenance of sister
chromatid cohesion
Overexpression of SPC1 ROS production (H2DCF-DA) [3]
Reduced actin dynamics
ubp10Δ ROS production (DHR 123) [6]
Deubiquitinating enzyme
Wbp1-1 ROS production (DHR 123) Addition of antioxidant or heterologous expression
of Bcl-2 increase viability
[200]
Defects in N-glycosilation
Physiological status
Aminoacid starvation ROS production (DHR 123) [1]
Replicative aging ROS production in mitochondria [201]
Chronological aging ROS production (DHR 123) [202]
Mutants with impaired mitochondrial function dye faster [25]
Sod2 activity decreased [203]
aif1Δ more resistant [11]
Death requires mitochondrial function [57]
ndi1Δ and nde1Δ increase life span [17]
dnm1Δ increase life span [116]
nuc1Δ more resistant in glycerol grown cells [10]
mmi1Δ more resistant [50]
DHR123 (dihydrorhodamine 123); H2DFDA (dichlorodihydroﬂuorescein diacetate); DE (dihydroethidium); NBT (nitro blue tetrazolium).
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per se is not indicative of mitochondrial involvement unless a
mitochondria-speciﬁc probe is used, or if co-localization is performed.
In fact, although it can be argued that mitochondria are the site of
major ROS production in normal cells, under a death stimulus ROS
production can occur in different cell locations. The involvement of
mitochondria in yeast apoptosis was supported by adding evidence
other than ROS assessment. Acetic acidwas theﬁrst apoptotic stimulus
[7] that was clearly shown to induce a mitochondria-dependent
pathway [8]. Biochemical and molecular approaches revealed that
acetic acid induces release of cyt c to the cytosol, decrease in
respiration and in the amount of cytochrome c oxidase (COX) II
subunit and cytochromes a+a3 [8]. Additional studies further impli-
cated other mitochondrial proteins in the execution of the apoptotic
program induced by acetic acid, namely: Fis1p, Dnm1p, Mdv1p, Aif1p,
Nuc1p, Aac proteins and Por1p [9–12]. Release of cyt cwas also shown
in cells treated with amiodarone [13], H2O2 [12] and in asf1/cia1Δ [14]
or Cdc48S565G mutants [15]. Complexes III and IV were found to be
involved in death induced by amiodarone [13] or abnormal telomeres
(cdc13Δ) [16], respectively, while deletion of different genes encoding
proteins from the electron transport chain rendered cells more
sensitive to apoptosis induced by overexpression of yeast Aif-
homologous mitochondrion-associated inducer of death (AMID)
orthologue, NDI1 [17]. Formation of petites was shown to accompany
apoptotic cell death induced by glucose (2%, w/v) in the absence of
additional nutrients [18]. Decrease of mitochondrial membrane
potential was observed for cell death induced by arsenite [19],
edelfosine [20] and reduced actin dynamics (act1–195, end3Δ and
sla1Δ118–511) [21]. In the case of high glucose and sorbitol-induced
apoptosis, mitochondrial swelling and reduction of cristae number as
well as a higher resistance of cyc1Δcyc7Δ mutant, lacking the two
isoforms of cyt c, or cyc3Δmutant, lacking cyt c heme lyase (essential
for the covalent binding of the heme group to apocytochrome c) were
demonstrated [22]. The former mutant also displayed higher resis-
tance to death induced by pheromone [23], while the latter was more
resistant to acetic acid [8]. Recently, ethanol was also shown to induce
apoptotic cell death that was accompanied by ROS production and
mitochondrial fragmentation [24]. Though mitochondrial fragmenta-
tion also occurs under certain physiological conditions and during
autophagy, it seems to be a common event in several mitochondria
apoptotic pathways, being previously observed in cells treated with
acetic acid and H2O2 [9,57]. In agreement with an active role of mito-chondria in the execution of the apoptotic program, Rho0mutants have
been shown to display increased resistance to many apoptotic stimuli
[8,19,23,198]. In addition, for some stimuli the higher resistance of
Rho0 mutants was accompanied by a decrease in ROS levels. This
identiﬁes mitochondria as the major site of ROS production, and
implicates ROS as a component of the apoptotic cascade. However, the
signalling role of ROS was questioned by other studies involving
different mutations, since no correlation between ROS production and
death levels was observed [12,23,25]. Conciliating the different data, a
possible explanation for ROS accumulation in mutants resistant to
apoptosis could be the occurrence in suchmutants of a blockage in the
apoptotic cascade downstream of ROS production.
ROS production was also observed in Candida albicans undergoing
acetic acid, H2O2 and amphotericin B induced apoptosis [26], and for
Schizosaccharomyces pombe, in apoptosis induced by chronological
aging, palmitate or by the accumulation of diacylglycerol (plh1Δdga1Δ
mutant) [27,204] (Table 2). Acetic acid induced apoptosis associated
with mitochondrial ultrastructural alterations, such as decrease of the
cristae number, formation of myelinic bodies and swelling was
reported for Zygosaccharomyces bailii [28] (Table 2).
3. Mitochondria apoptotic signalling pathways
To date, most studies regarding yeast apoptosis have covered
mainly the identiﬁcation of different apoptotic triggers and the
components/regulators of apoptotic death. Hence, few reports on the
apoptotic-related signal transduction pathways have been published.
In this section we will refer several functional genetic analysis and
pharmacological-based approaches which allowed identifying com-
ponents of yeast signalling cascades that similarly to their mammalian
counterparts, are involved in conveying the information to the
apoptotic apparatus. Not surprisingly cell death signalling pathways
in high eukaryotes are conserved and involved in the modulation of
apoptosis in yeast (Fig. 1).
The ﬁrst evidence linking Ca2+/calmodulin/calcineurin signalling to
programmed cell death (PCD) came from the study by Huh et al. [29]
which showed that yeast calcineurin-deﬁcient (cnb1Δ) strain is more
sensitive to salt-induced PCD. Calcineurin (a PP2B phosphatase)
modulates Na+ homeostasis through the transcription factor Tcn1p/
Crz1p which is translocated from the cytosol to the nucleus after de-
phosphorylation [30]. Once in the nucleus it activates the transcription
of multiple genes including ENA1, which codes for a P-type ATPase. The
Table 2
Compounds, gene alterations and physiological conditions that induce mitochondria-
associated apoptosis in non-Saccharomyces yeasts
Trigger Effects on mitochondria Additional evidences
of mitochondrial
involvement
References
Candida albicans
Acetic acid ROS production (DHR 123) [26]
H2O2
Amphotericin B
Schizosaccharomyces pombe
Palmitate or
oleate
ROS production (DE) [27]
plh1, dga1
double deletion
ROS production (DE) [27]
Diacylglycerol
accumulation
Chronological
aging
ROS production (DHR123) [204]
Zygosaccharomyces bailii
Acetic acid Decreased ΔΨm [28]
Decrease of the cristae number,
formation of myelinic
bodies and swelling
DHR123 (dihydrorhodamine 123); DE dihydroethidium).
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mutant as well as of the wild-type, but had no effect on the NaCl or
sorbitol sensitivity of the osmotic hypersensitive hog1Δ mutant. This
observation suggests amitochondria-dependent PCD and further linked
cell death in the response to the ion disequilibrium under salt stress. In
addition, Bcl-2 suppression of cnb1Δ salt sensitivity was ENA1-
dependent, due in part to transcriptional activation.Fig. 1. Mitochondria-dependent apoptotic signalling pathways. The main signalling pathw
activated by actin cytoskeleton remodelling/dysfunctions and in response to environmental s
The PKA catalytic subunit Tpk3p probably targets directly F-actin regulating proteins andmit
system was shown to inhibit apoptosis. The same stimulus seems to be able to trigger mo
coordinated cell demise. The question mark for acetic acid denotes the lack of evidence sup
indicates the absence of evidence linking the pathway activated by this antifungal protein tA link between the mitogen-activated protein kinase (MAPK)
signalling pathway and cell death in S. cerevisiae had been previously
supported by the observation that the plant defense osmotin
stimulates a MAPK cascade to induce alterations in the cell wall that
enhance cytotoxicity of this antifungal protein [31], and ultimately
leads to apoptotic-like cell death [32]. It was concluded that osmotin
enhances pro-apoptotic ROS production through the speciﬁc activa-
tion of the RAS2/cAMP/cAMP-dependent protein kinase (PKA) path-
way (rather than through Ras–MAPK signalling), which in turn
suppresses Yap1-response element (YRE) and stress response ele-
ments (STRE)-mediated antioxidant stress responses. ROS signals have
been shown to mediate osmotin-induced apoptosis and abnormal
mitochondrial morphology has been observed in osmotin-treated
cells [30]. However, neither treatment with oligomycin nor the
absence of mitochondrial DNA or of Atp4p had any effect on yeast
response to osmotin. Moreover, overexpression of Bcl-2 did not alter
susceptibility to this protein. Therefore the role of mitochondria in
osmotin-induced apoptosis, if any, is distinct from their involvement
in apoptosis-induced by other triggers [32]. Whether Ras signalling is
transmitted to mitochondria has also to be clariﬁed.
S. cerevisiae Ras proteins, like its mammalian counterparts [33] can
perform both pro- and anti-apoptotic functions [32]. The ﬁnal cell
response, either enhancement of survival, differentiation or apoptosis
depends on the cell type and on the activating signal [33]. Ras2p-
dependent suppression of the stress response has been reported to
have opposite effects namely in promoting invasive growth [34] or
apoptosis induced by osmotin [32]. As discussed by Narasimhan et al.
[32] what determines the cell decision to commit to apoptosis or to
differentiation, remains to be ascertained.
Since MAP kinase and cAMP signalling cascades have been
involved in morphogenesis signalling in different fungi [35] the
interrelationship between cell death and fungal morphogenesis/
differentiation has also been a matter of research [32].ays involved in yeast apoptosis include the RAS–cAMP–PKA pathway which can be
tresses. Actin dysfunction is able to trigger apoptosis independently of the Ras pathway.
ochondria contributing to the accumulation of toxic radicals. The calmodulin/calcineurin
re than one pathway reinforcing the interplay between different pathways leading to
porting the activation of the MAP kinase pathway, and the question mark for osmotin
o mitochondria.
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H2O2 switch fromyeast to hyphae [26]. Yet this morphogenic switch in
C. albicans is independent of the known morphogenic related
signalling components (CPH1, TEC1, RIM101 and EFG1). Since C. albicans
treated with pro-apoptotic doses of amphotericin B did not switch
from yeast to hyphae it was suggested that the signalling pathways
engaged in apoptosis and in morphogenetic switch diverge at some
point. Ras pathway was also involved in apoptosis signalling in
C. albicans [36].Mutations that block Ras–cAMP–PKA signalling (ras1Δ,
cdc35Δ, tpk1Δ, and tpk2Δ) suppress or delay the apoptotic response,
whereas mutations that stimulate signalling (RAS1val13 and pde2Δ)
accelerate the rate of entry into apoptosis. Consistently, pharmacolo-
gical inhibition or stimulation of Ras signalling delay or promote
apoptosis. Similar to C. albicans ras1 mutant [36], RAS2 deletion is
able to decrease cell death induced by acetic acid in S. cerevisiae.
Furthermore, a transient increase in cAMP and a decline in both
isoforms of the regulatory subunit of PKA (Bcy1p(1) and Bcy1p(2))
were observed in cells committed to apoptosis. It remains to be
elucidated whether Ras–cAMP signals can be conveyed through PKA-
independent pathways and if they regulate apoptosis in C. albicans by
mitochondria-mediated or non-mediated pathways.
Yeast cells commit to PCD when exposed to a high pheromone
concentration of the opposite mating type and in the absence of the
mating partner [23]. The observation of increased resistance to
pheromone in the absence of mitochondrial DNA (Rho0 mutant) or of
both isoforms of cyt c (cyc1Δcyc7Δ mutant) suggested that phero-
mone-induced apoptosis is mediated by a mitochondrial pathway.
Since yeast cellswith compromised calmodulin/calcineurin systemare
more susceptible to pheromone-induced apoptosis [23] it appears
that, like for salt [29], this signalling pathway acts to inhibit apoptosis.
Pheromone-induced apoptosis was rescued in a mutant lacking the
Ste20p, a crucial kinase of theMAPKmating pathway and consistently,
cell death was cycloheximide-inhibitable. Together these results
suggested that the pheromone death cascade includes a calmodulin/
calcineurin-MAPK. Later on, it was found that pheromone-activated
MAPK signalling, similarly to the drug amiodarone, elicited an increase
in intracellular Ca2+ levels and subsequently a mitochondrial hyper-
polarization and activation of respiration coupled to energy produc-
tion [13]. In turn, these changes ensue in ROSproduction by respiratory
complex III, mitochondrial fragmentation and cyt c release.
Because an increase in intracellular Ca2+ concentration was also
found in response to acetic acid (Pereira, C., Sousa, M.J. and Côrte-Real
M., unpublished data) together with a transient mitochondrial
hyperpolarization and ROS production [8], it appears that pheromone,
acetic acid and amiodarone converge to common death pathways.
Since both pheromone- and acetic acid-induced apoptosis are
inhibited by cycloheximide it presumes transcriptional activation of
target genes by upstream signalling cascades. Indeed, as referred
above it was shown that pheromone activates a calmodulin/
calcineurin-controlled MAPK pathway [23] and that Ras pathway
signals yeast apoptosis induced by harsh environmental stress, such as
acetic acid or H2O2 [36]. Intracellular Ca2+ increase and ROS
production are common features in these three scenarios whereas
intracellular acidiﬁcationwas only reported when death is induced by
weak carboxylic acids, including acetic acid [37]. Notably, chronolo-
gical aging-induced death is associated to acidiﬁcation of the medium,
and neutralization by pH buffering compounds abolishes death. Sod2p
and signalling through Ras–cAMP–PKA including the transcription
factorsMsn2p andMsn4p, were also shown to play a crucial role in the
regulation of yeast chronological aging and death program [38]. It is
known that the efﬁciency of the two recognized physiological suicide
triggers, namely pheromones and chronological aging, is quite lower
than the one obtained with harsh environmental stresses. Whether
such difference depends on the nature/amplitude of the intracellular
signal(s) generated in response to the environmental cue, or to the
simultaneous activation of different transduction pathways, whichcan amplify the initial signal and accelerate the onset of death,
remains to be ascertained.
Recently, other authors reported that the mechanisms underlying
cell dead induced by pheromone were dose dependent and involved
three genetically independent signalling pathways [39]. It was shown
that rapid cell death wasmediated by Fig1p, a transmembrane protein
homologous to PMP-22/EMP/MP20/Claudin proteins, although it is
independent of its Ca2+ inﬂux activity. This fast death also required cell
wall degradation, which was inhibited in some surviving cells by the
activation of a negative feedback loop involving the MAP kinase Slt2/
Mpk1p. While mutants lacking Slt2/Mpk1p or its upstream regulators
underwent a Fig1p-independent cell death, occurring at intermediate
rates and much lower concentrations of pheromone, calcineurin-
deﬁcient cells displayed a third wave of cell death that was Fig1p and
Slt2p/Mpk1p independent. All three modes of cell death were
independent of mitochondrial cyclophilin (Cpr3p), of the yeast
metacaspase (Yca1p) and of different mitochondrial ﬁssion proteins
(Fis1p, Dnm1p, Mdv1p). In addition, mitochondrial respiration was
only required for the slowest death in calcineurin-deﬁcient cells. All
threemodes of cell death exhibited ROS production but did not exhibit
chromatin condensation, DNA fragmentation and preservation of
plasmamembrane integrity. Therefore, Zhang et al. [39] proposed that
yeast cells in response to pheromone die by necrosis-like processes
whenever they fail to mate in the absence of a mating partner (Fig1p-
dependent fast death), or to perform essential functions that are
necessary for cell survival in mating conditions (slow deaths in
calcineurin and MAPK-less mutants).
It was also reported that pradimicin, amannose-binding antifungal
antibiotic, induces an apoptosis-like cell death in S. cerevisiae [40]
which is mediated by the membrane-spanning osomosensor, Sln1p
[41]. Ypd1p is located downstream Sln1p and transfers a phosphoryl
group from this sensor kinase to the two response regulators Ssk1p
and Skn7p. The former regulates the downstream HOG–MAPK
pathway in response to osmotic stress while the latter regulates
response to oxidative stress and cell wall damage. Though pradimicin
fungicidal action depends of Sln1p, the downstream branches, Ssk1p
and the HOG pathway are not involved.
It was found that regulation of actin dynamics has a central role in
aging and apoptosis signalling [21,42]. Decrease in actin dynamics,
caused by addition of drugs or mutations in End3p and Sla1p, engaged
in the maintenance of F-actin in cortical patches, provokes a
depolarization of the mitochondrial membrane, and an increase in
ROS production resulting in cell death. In contrast, increasing actin
dynamics, either by a speciﬁc actin allele or by deletion of a gene
encoding the actin bundling protein Scp1p, reduces production of ROS
and increases lifespan of yeast. Overexpression of the ubiquitin ligase
Rsp5p alleviated the oxidative stress phenotype observed in cells
lacking End3p by targeting Sla1p to the cortex and restoring actin
remodelling capability. Furthermore, itwas shown that overexpression
of PDE2, a negative regulator of the Ras/cAMP pathway which
hydrolyses cAMP preventing PKA activation and derepressing the
stress response, suppressed end3Δ hypersensitive apoptotic pheno-
type. Indeed it rescued actin dynamics, reduced oxidative stress
sensitivity and restored viability, pointing to a hyperactivation of Ras2/
cAMP in end3Δ cells. It was demonstrated that the consequent increase
in cAMP levels drives the mitochondrial dysfunction and cell death. In
addition ROS production is most likely the result of dysfunctional
mitochondria since it also can be prevented by the inhibition of the
respiratory chain function [21,42]. However, because overexpression of
PDE2was unable to rescue other phenotypic features of end3Δ, such as
failure to accumulate glycogen and to adapt to different environmental
stresses [21,43–45], which are shared with the constitutively active
RAS2val19, it is proposed that ROS accumulation occurs through a PKA-
independent pathway. Additionally, Gourlay and Ayscough [42]
showed that actin-induced mitochondrial ROS production entails the
actin regulatoryprotein Srv2p/CAP,which also binds adenylate cyclase,
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depolarization and ROS production in response to increase in cAMP
levels due to PDE2 deletion [42] was demonstrated to be mainly
dependent on the Tpk3p subunit of PKA, since cells lacking both Tpk3p
and Pde2p did not display mitochondrial depolarization, ROS accu-
mulation and actin aggregation. Consistently, absence of Tpk3p in
actin-stabilized end3Δ decreased ROS production and actin aggrega-
tion. Nevertheless, Tpk3p appears to have other functions. It was
revealed that Tpk3p is involved in the regulation of the mitochondrial
enzyme content [46] and it is likely that it can imbalance respiratory
chain components, hence causing ROS accumulation in cells with actin
dynamics affected. Additionally, because Tpk3p loss inhibits actin
aggregation in end3Δ, and addition of cAMP to cells lacking Pde2p
leads toTpk3p-dependent F-actin stabilization, it was claimed that this
PKA subunit has cytoskeletal targets and regulates actin dynamics [46].
In summary, it is proposed that in actin-stabilized cells the hyper-
activation of Ras signalling and actin aggregation act together to set up
apoptotic cell death. The frequent observation in aging yeast of
formationof F-actin aggregates due to a decline ofﬁlamentous actin (F-
actin) supports the interpretation that changes in actin dynamics
might regulate the elimination of aged cells from a population by
inducing apoptosis [42]. Recently, Farah et al. [47] discovered that the
oxidation state of two conserved cysteine residues (C285 and C374) of
actin is able to regulate cell death. Oxidation of actin leads to a
hyperstabilization and subsequently to ROS formation and cell death.
The oxidoreductase Oye2p is suggested to protect cells from dying by
preventing this oxidation-induced hyperstabilization of the actin
cytoskeleton. Interestingly actin was also suggested to play an
important role in regulation and execution of apoptosis in higher
eukaryotes [48,49].
4. Mitochondrial proteins involved in apoptotic cell
death regulation
The study of yeast mutants defective in genes encoding mitochon-
drial proteins enabled to identify regulators/mediators of apoptosis in
this organism (Fig. 2). These proteins are components of the electron
transport chain and of the inner or outer mitochondrial membranes
(IMM and OMM, respectively). While most of the yeast mitochondrial
proteins recognized as implicated in apoptosis have their mammalianFig. 2. Mitochondrial proteins involved in the regulation of yeast apoptotic cell deathcounterparts also involved in apoptosis, a few were only identiﬁed in
yeast (e.g. Ysp1p and Ysp2p). Some of those yeast mitochondrial pro-
teins, like their mammalian akin, are translocated from the mitochon-
dria to the cytosol (cyt c) or to the nucleus (Aif1p and Nuc1p), others
are proposed to be involved in themitochondrial permeabilization and
release of the former proteins (Aac1p, Aac2p and Aac3p, and Por1p), or
in the ﬁssion/fusion of mitochondria (Dnm1p, Mdv1/Net2, Fis1p,
Ysp1p and Ysp2p). All these proteins will be discussed in section 4.
Here wewill focus on the yeast orthologues of: the mammalian AMID,
Ndi1p; the human translationally controlled tumor protein (TCTP),
Mmi1p; and the human mitochondrial ribosomal protein, Dap3/
Rsm23.
Ndi1p, an inner membrane mitochondrial NADH dehydrogenase,
which is the ﬁrst component of the electron transport chain, was found
to be the closest yeast orthologue to mammalian AMID proteins [17].
While disruption of NDI1 or NDE1, a orthologue of NDI1 that localizes
at the external side of the IMM, resulted in increased life span,
overexpression of NDI1, but not of NDE1, resulted in the appearance of
typical apoptotic markers. Differences in the effect of the two genes
were associated to differences in the location of ROS production, which
was observed to occur essentially at mitochondrial level in NDI1-
overexpressing cells, whereas Nde1p induced mainly cytosolic ROS
production. The authors suggest that Ndi1p-induced apoptosis could
result from alterations in the electron transport chain due to increased
internal NADH dehydrogenase activity.
Mitochondria–microtubule interactions have also been suggested
to contribute to yeast apoptosis. In fact, it was recently shown that
Mmi1p (YKL056c), the yeast orthologue of human TCTP, translocates
to mitochondria upon an apoptotic stimulus where it reversibly
attaches to the outer surface of the mitochondria.mmi1Δmutant was
sensitive to benomyl pointing that the protein may interact with yeast
microtubules [50].
Dap3, usually referred as Rsm23p, is another yeast mitochondrial
protein that seems to be involved in apoptosis. In human cells, death
associated protein 3 (DAP-3) is a mitochondrial protein found by an
antisense mRNA expression rescue screen in HeLa cells. This protein is
able to positively regulate apoptosis induced by interferon gamma
[51], activate fragment apoptosis stimulating (FAS) or tumor necrosis
factor alpha (TNFα) [52]. The degree of homology between Rsm23p
and hDAP-3 is relatively low, but a putative ATP/GTP binding P-loop. The localization of Ysp1p and Ysp2p at the OMM in the scheme is speculative.
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complement the mitochondrial dysfunction phenotype of a yeast
RSM23 deletion mutant [53]. In S. cerevisiae, RSM23 was also found
among deletion mutants more sensitive to cell death induced by a
mitochondria targeting angiogenesis inhibitor [54]. In contrast, a yeast
deletion mutant of RSM23 prevented the TUNEL positive phenotype
induced by 44 h of YCA1 overexpression [55] indicating that its pro-
apoptotic function is conserved in yeast. Prevention of the apoptotic
inducing effect of overexpressing YCA1 in dap3/rsm23Δ was the ﬁrst
indication that Yca1p may exert its action upstream of mitochondrial
alterations during cell aging. Additional evidence of Yca1p involve-
ment on themodulation of mitochondrial alterations was obtained for
H2O2-induced apoptosis. Under these conditions, the absence of
Yca1p revert the loss of mitochondrial DNA staining [55] and
decreased the percentage of cells with fragmented mitochondria
[56,57]. Furthermore, the double knockout yca1Δﬁs1Δ could restore
viability of ﬁs1Δ mutant in response to H2O2 and acetic acid [9]. Also
in favor of a role of caspase upstream mitochondria was the
observation that the increase in caspase activity detected in act1-159
mutant was still observed in a Rho0 of this mutant, although this strain
was much more resistant [3]. On the contrary, in hyperosmotic stress
induced apoptosis Yca1p appears to act downstream mitochondria
[22]. This study showed a partial dependence of caspase activation on
cyt c. Hence it is conceivable that, like mammalian cells, yeast
possesses a feedback mechanism involved in the ampliﬁcation of
caspase activation by cyt c.
5. Mitochondrial permeabilization, proteins released and
network fragmentation
5.1. Mitochondrial outer membrane permeabilization in yeast
In mammalian cells, mitochondrial outer membrane permeabiliza-
tion (MOMP) is a decisive event in apoptosis due to the release of lethal
factors, like cyt c, AIF and EndoG. Additionally, MOMP may also lead
to cell death by lethal ROS production or destruction of mito-
chondrial functions. In mammalians MOMP has been attributed to:
i) the formation of the PTP, an inner membrane large unselective
channel that, when in the open state, should lead to large amplitude
swelling with rupture of the OMM; ii) the Bcl-2 pro-apoptotic family
members, through the formation of pores in the OMM; or iii)
interactions between both (for recent reviews see [58–60]). Yeast
does not possess obvious orthologues of Bcl-2 family members, but
the core components ascribed to the mammalian PTP, (ANT, Adenine
Nucleotide Translocator; VDAC, Voltage Dependent Anion Channel;
and cyclophilin D) are highly conserved among eukaryotic organisms.
In the yeast S. cerevisiae there are three isoforms of the ADP/ATP
carrier, orthologues of ANT, encoded by the genes AAC1, AAC2, AAC3,
whose expression is differentially regulated by environmental con-
ditions [61–63]. Yeast also possesses two VDAC genes, POR1 and
POR2, with POR1 coding for the major isoform, and a mitochondrial
cyclophilin, Cpr3p, known to be involved in the protein folding
process [64].
Most of the studies concerning the role of putative PTP compo-
nents in death and mitochondrial permeabilization in yeast have been
done in cells expressing the heterologous pro-apoptotic Bax protein.
Although contradictory, the results obtained pointed to a negligible
role of such components in Bax-induced cell death (discussed in
section 6). In mammalian systems Bax alone, or together with other
pro-apoptotic members of the Bcl-2 family, has proven to be sufﬁcient
to induce mitochondrial membrane permeabilization [65,66]. There-
fore, heterologous expression of Bax in yeast does not appear suitable
to study components of alternative modes of mitochondrial mem-
brane permeabilization. Instead, the use of stimuli that elicit activation
of the yeast apoptotic machinery will be more adequate to ﬁnd such
alternative components.Like mammalian mitochondria, yeast mitochondria have the
ability to form, under certain conditions, an inner membrane large-
conductance unselective channel similar in size to its mammalian
counterpart. However, the different regulatory properties of the yeast
mitochondrial unselective channel (YMUC), also called yeast PTP [67],
make it a controversial counterpart of the mammalian PTP (reviewed
in [68]). While the mammalian PTP is opened in the presence of Ca2+
and phosphate (Pi) and closed by ATP and cyclosporin A (CsA) [69], the
YMUC is induced by ATP and respiratory substrates and closed by high
Pi concentrations [70,71]. Additionally, YMUC is insensitive to CsA
[67,72,73] although yeast possess a CsA inhibitable mitochondrial
cyclophilin [64]. The question of the Ca2+ effect on YMUC is more
complicated since all the possible scenarios (no effect, inhibition or
stimulation) were reported. Hence, we follow with a more detailed
discussion of these scenarios. High Ca2+ levels have been described as
causing no effect in yeast PTP induction [67,74]. However, S. cerevisiae
does not have a mitochondrial Ca2+ uniporter equivalent to the
mammalian one [75] and this could account for Ca2+ resistance. This
hypothesis was convincingly discarded by Jung et al. [67] who showed
that large amounts of Ca2+ can be accumulated in brewer yeast
mitochondria in the presence of the Ca2+ ionophore ETH129 and Pi,
without PTP induction. Additionally, in contrast to S. cerevisiae, En-
domyces magnusii, possesses mitochondrial systems for Ca2+ inﬂux
and efﬂux effectively regulated and also do not exhibit the classical Ca2+
dependent PTP-induction [76]. Both the functionality of the YMUC
and its molecular composition are uncertain at the moment. The
participation of the inner membrane AAC [77] or VDAC in the Ca2+
insensitive pore has been dismissed [78]. Nevertheless carboxyatrac-
tyloside, an ANT speciﬁc ligand is able to inhibit pore formation [79]
and in por1Δ cells, although the large-conductance channel is still
detected, its voltage dependence is altered [80]. The fact that YMUC is
not sensitive to CsA, although yeast possesses a CsA inhibitable
mitochondrial cyclophilin, as referred above, makes this protein an
unlikely component of YMUC.
Other authors found an inhibitory effect of Ca2+ on YMUC [81] and
later on, VDAC was pointed as the site of Ca2+ action since in a por1Δ
strain, Ca2+ was no longer inhibitor [72]. The sensing of Ca2+ by an
outer membrane protein would override the problem of Ca2+ uptake
by S. cerevisiae mitochondria.
Despite all these data, a Ca2+ and Pi-dependent, CsA insensitive pore
did arise in S. cerevisiae in response to ATP [73]. Formation of this pore,
which molecular composition was not investigated, required the
presence of the cross-linking agent phenylarsine oxide (PhAsO) or
inhibitors of catalase, and was facilitated in mutants lacking the
thioredoxin peroxidase gene [73]. This yeast PTP induction was
accompanied by enhanced H2O2 production and decreased cell
viability. The Ca2+-induced yeast PTP seems to require overcoming the
yeast highly active antioxidant system. The potential involvement of
this pore in yeast apoptotic scenarios can be easily conciliated with the
observation that oxidative stress is a common point in all the yeast
apoptotic scenarios. An increase in mitochondrial ROS is often
accompanied by cyt c release, indicating the occurrence of outer
membrane permeabilization, even in the absence of heterologous
expression of Bcl-2 family members [8,13–15]. Under acetic acid
treatment conditions shown to cause MOMP [12], a rise in cytosolic
Ca2+ was also observed (Pereira, C., Sousa, M.J. and Côrte-Real M.,
unpublished data). Pozniakovsky and co-authors reported a similar
increase in cytosolic Ca2+ in cells undergoing amiodarone-induced
apoptosis [13]. In addition, it was shown that overexpression of Arabi-
dopsis thaliana BI-1 (Bax inhibitor-1) does not suppress Bax-induced
cell death in S. cerevisiaemutants lacking endoplasmic reticulum Ca2+-
ATPase (Pmr1or Spf1), supporting a role for Ca2+ inyeast cell death [82].
While the absence of effect of CsA on yeast PTP was consensual
[67,72,73], the effect of this compound on cell death is less clear
[11,12,23]. However, Pereira et al. [12] showed that in addition to the
lack of CsA effect, the absence of mitochondrial cyclophilin did not
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strongly supports the view that CsA and its target cyclophilin are not
involved in yeast apoptosis.
It was recently shown that AAC proteins are required for the release
of two inner mitochondrial space proteins, cyt c and adenylate kinase
[12]. Intriguingly, in a aac1/2/3Δ mutant the retained cyt c becomes
degraded, though not speciﬁcally since Atp2p, another protein from
innermembrane, is also degraded. Ultrastructural studies showed that
degradation of mitochondria during apoptosis can involve a speciﬁc
degradation of the IMM or of the OMM [83]. It can be speculated
that the absence of AAC proteins can preferentially trigger the IMM
degradation pathway.
Regarding Por1p, a higher sensitivity to acetic acid, H2O2 and
diamidewas reported in the absence of this protein [12]. Particularly, a
fast outcome in the apoptotic features induced by acetic acid was
observed in this mutant, especially concerning DNA degradation. It
was suggested that this protein may have an inhibitory effect in cell
death since its absence accelerates death. Consistently, when the three
isoforms of VDAC were deleted in a ﬁbroblast cell line cell death was
exacerbated [84]. Absence of the yeast second isoform of VDAC, Por2p,
did not affect cell death induced by acetic acid (Pereira, C., Sousa, M.J.
and Côrte-Real M., unpublished data). Unexpectedly, both strains
lacking the AAC's or VDAC proteins were shown to be highly resistant
to cell killing induced by heterologous expression of the viral protein R
(Vpr) encoded by HIV-1 [85].
Together these ﬁndings while supporting the view that mitochon-
drial cyclophilin is not a component of the Yeast PTP [12], revive the
discussion about two other putative components, AAC and VDAC.
Much work will be needed not only to elucidate the molecular
composition and regulation of the Yeast PTP but also, most
importantly, to clarify its role on yeast cell death.
5.2. Mitochondrial proteins released
The release of sequestered proteins from the intermembrane
space to the cytosol is the main contribution of mitochondria to cell
death. In mammalian apoptosis these proteins can lead to cell demise
depending on the activation of members of the cysteine protease
family, the caspases, or independently of these executioners. Cyt c,
Smac/DIABLO (second mitochondria-derived activator of caspases/
direct inhibitor of apoptosis protein (IAP)-binding protein with low
pI) and HtrA2/Omi (high temperature requirement protein A2), are
among the caspase-dependent factors, while caspase-independent
factors include AIF and EndoG [86]. In yeast, orthologues of cyt c, AIF,
EndoG and HtrA2/Omi were uncovered and their roles in cell death
have been assessed. While cyt c, Aif1p and Nuc1p were shown to
have a mitochondrial localization from where they escape upon
apoptotic induction [8,10,11], the yeast orthologue of HtrA2,
Nma111p [56], unlike its mammalian counterpart is not predomi-
natly localized in mitochondria but in the nucleus, where it remains
upon apoptotic induction, and as such it will not be included in this
section.
5.2.1. Cytochrome c
Cyt c is a soluble heme containing protein loosely attached to the
IMM. Cyt c is highly conserved between species, found in plants,
animals, andmany unicellular eukaryotes. It is formed in the cytosol as
an apoproteinwhich is then ﬁttedwith a heme group during transport
through the OMM.
Cyt c is released, along with other apoptotic proteins, from the
mitochondria in response to pro-apoptotic stimuli in several cell lines
[87,88]. Cyt c was the ﬁrst mitochondrial protein with apoptotic
function identiﬁed and established the general importance of mito-
chondria in apoptosis. Once released from mammalian mitochondria,
it forms a complex in the cytosol with the apoptosis-protease
activating factor 1 (APAF-1) [89] and ATP/dATP (2′-deoxyadenosine5′-triphosphate) to form a structure called the apoptosome. The
apoptosome binds up to seven caspase-9 proteins activating them.
Interestingly, the C. elegans APAF-1 orthologue CED-4 does not bind to
cyt c, instead it is constitutively active. CED-4 is kept at bay by the
inhibitor of apoptosis protein DIAP-1.
As referred in section 2, S. cerevisiaemitochondria also release cyt c
in response to various apoptotic stimuli like acetic acid [8], amiodarone
[13], H2O2 [12] and inyeast strains lacking the histone chaperone ASF1/
CIA1 [14] or with a mutation in CDC48 (cdc48S565G) [15]. Heterologous
expression of the mammalian protein BAX [90] also triggers cyt c
release (see section 6). Absence of cyt c or its mature form, leads
to a delay in response to several death stimuli, including Bax
[8,13,22,23,91–93], but has no effect on death kinetics induced by
ethanol. When apoptosis is triggered by hyperosmotic stress, cyc3Δ
and cyc1Δcyc7Δ deletions showed decreased death rates associated
with decreased caspase activation [22]. For acetic acid-induced
apoptosis lack of cyt c releasewas associated to an increased resistance
[8] but no relation was found between cyt c release and caspase
activation [12]. These results point to a possible role of cyt c in
activating caspases although in a stimuli-dependent manner and
suggest that it can also act by a caspase-independent mechanism.
5.2.2. Apoptosis inducing factor
The apoptosis inducing factor, AIF was puriﬁed from rat liver
mitochondria by Susin et al. [94] and the corresponding mouse and
human genes were cloned. In response to apoptotic stimuli, AIF is
released from mitochondria and translocated to the nucleus. Its
release has been linked to chromatin condensation and digestion into
50 kb fragments, possibly causing the high molecular weight DNA
fragmentation reported previously for mammalians [95] and also
found in yeast [96]. S. cerevisiae carries a distant orthologue of the
mammalian AIF gene called yAIF1/YNR074c. This protein has a short
yeast mitochondrial presequence (predicted to extend from amino
acids 1-21) in place of the large presequence of mammalian AIF. The
yeast and mammalian AIF share homology mainly in a region
encompassing a NADH/FAD binding domain which is described by
the PF07992 protein proﬁle (PFAM database [97] at http://pfam.
sanger.ac.uk/ for the human AIF protein sequence, accession number
O95831). There is little homology outside this area, but yeast Aif1p
was nevertheless shown to regulate apoptosis in a manner similar to
mammalian AIF [11]. It is required for cell death induced by acetic acid,
H2O2 and long term culture. Under these apoptotic induction
conditions yeast Aifp also translocates from the mitochondria to the
nucleus, and, like its mammalian akin, is dependent on cyclophilin A
[11]. The partial dependence of Aif1p on a metacaspase has so far, only
been observed in yeast. Absence of Aif1p stimulated death induced by
Bax [98] and had no effect on death triggered by hyperosmotic stress
[22], aging in yeast colonies [99] or ethanol stress [24]. Thus, Aif1p-
mediated cell death seems to be dependent on the stimuli used.
5.2.3. Endonuclease G
EndoG is another apoptotic mammalian mitochondrial protein for
which there is a yeast orthologue. EndoG is a mitochondrial nuclease
ﬁrst identiﬁed in rat [100] and C. elegans [101]. It is released from
mitochondria and transferred to the nucleus where it causes DNA
fragmentation. Puriﬁed EndoG from mouse and C. elegans causes
internucleosomal laddering when added to isolated nuclei [100,101].
The yeast gene NUC1 encodes a mitochondrial DNA/RNA nuclease that
is important for mitochondrial DNA recombination [102,103]. Buttner
et al. [10] observed that Nuc1p usually localizes to the IMM but, under
apoptosis induction, translocates to the nucleus, leading to cell death.
Therefore, Nuc1p and EndoG appear to have a similar downstream
role, exerting their pro-death action upon exit frommitochondria and
translocation to the nucleus. In respiring cells, NUC1 deletion protects
from apoptosis induced by chronological aging, whereas in glucose
medium NUC1 deletion has the opposite effect [10]. Accordingly,
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based medium) was also shown to be more sensitive [24]. Over-
production of Nuc1p sensitizes cells to H2O2-mediated cell death [10].
The same authors showed, by a pull-down assay, that Nuc1p interacts
physically with two mitochondrial proteins, Aac2p and Por1p.
Deletion of AAC proteins reduced the sensitizing effect of NUC1
overexpression in response to H2O2, suggesting that these proteins
may have a role in Nuc1p-facilitated killing and possibly in its release
from mitochondria [10].
5.3. Mitochondrial fragmentation in apoptosis
Mitochondria are morphologically dynamic organelles that con-
tinuously fuse and divide to form interconnected tubular networks or
small round units within the cell [104]. The equilibrium between these
two shapes is achieved by regulating the relative rates of organelle
fusion and ﬁssion [105]. Mitochondrial ﬁssion is required prior to
mitosis to allow segregation of mitochondria to the daughter cells.
Mitochondria shape is also dependent on the cell type and metabolic
demands [106]. Among the known factors controlling mitochondrial
dynamics in healthy yeast cells are the proteins Dnm1p, Mdv1/Net2p
and Fis1p that form a complex involved in ﬁssion, and Fzo1p and
Mgm1p required for mitochondrial fusion [107–110].
It was observed that during a variety of apoptotic scenarios in
mammalian cells the interconnected mitochondrial network early
converts into punctiform morphology, a process known as thread–grain
transition (see for recent reviews [111–113]). This apoptotic fragmenta-
tionwas proposed to be due to the activation of the physiological ﬁssion
machinery, which proved also to inﬂuence the path of apoptosis [114].
Inhibition of themitochondrial ﬁssionmachinery inmammals, including
Drp1, orthologue of yeast Dnm1p, and Fis1p, impairs not only apoptotic
fragmentation of themitochondrial network but also cyt c release and the
process of death itself [114,115].When both events occur, the relationship
between cyt c and mitochondrial fragmentation is not clear.
In yeast apoptosis induced by different compounds [9,13,24,57] or
upon heterologous Bax expression [98], mitochondria also undergo
extensive fragmentation suggesting it to be a general feature of yeast
apoptosis. While deletion of DNM1 or MDV1/NET2 inhibits cell death,
deletion of FIS1 increases H2O2, acetic acid and heat shock-induced
apoptosis [9]. In agreement with these results dnm1Δ also showed an
increase in life span [116]. Interestingly, Dnm1p-deﬁciency protected
cells from death more efﬁciently than from mitochondrial fragmenta-
tion. This suggests that the absence of Dnm1p in yeast might confer
protection against cell death also by mechanisms other than those
related to ﬁssion of the mitochondria. In S. cerevisiae, Fis1p is evenly
distributed along the mitochondrial surface where it functions as a
receptor to recruit Dnm1p from the cytosol to mitochondria [108]. The
fact that the double mutant dnm1Δﬁs1Δ behaved like dnm1Δ lead
Fannjiang and et al. [9] to propose that Fis1p inhibits the action of
Dnm1p, promoting by this means cell survival. The pro-survival role of
Fis1p in yeast was a surprise since in mammalian cells overexpression
of FIS1 not only triggers mitochondrial ﬁssion but also cyt c release
and apoptosis [115]. This pro-survival role in yeast was further
supported by the sensitivity of ﬁs1Δ to death triggered by a viral pore-
forming toxin [117] and ethanol treatment [24]. Lack of DNM1 or
MDV1 did not signiﬁcantly alter ethanol-induced death process [24],
in contrast to the results obtained for acetic acid, H2O2 and heat shock
treatment [9], suggesting that different stimulus may involve different
components of the ﬁssion machinery.
The yeast metacaspase Yca1p was implied in the process of
apoptotic mitochondrial fragmentation, presumably as an upstream
regulator of the process since absence of YCA1 decreased fragmenta-
tion of themitochondrial network caused both by H2O2 treatment and
by expression of a truncated form of Kluyveromyces lactis Lsm4p. This
protein is involved in messenger RNA decapping and cells expressing
the truncated form exhibit markers of apoptosis [57,118].Two novel proteins affecting the fragmentation of mitochondrial
reticulum were identiﬁed in genetic screens for proteins involved in
the pheromone or amiodarone-induced cell death [13,37]. These
proteins were named yeast suicide protein 1 (Ysp1), and yeast suicide
protein 2 (Ysp2), and are both localized tomitochondria and necessary
for mitochondrial fragmentation in the course of apoptosis [13,37].
Mitochondrial fragmentation per se does not result in cell death
either in mammals [119] or yeast [9]. Moreover, the multiple
components of the mitochondrial morphogenesis machinery seem
to be able to positively and negatively regulate apoptosis. It must be
said, however, that extensive fragmentation of the network is not
exclusive to apoptosis; during nitrogen starvation or treatment with
the drug rapamycin, both autophagy-inducing conditions, the frag-
mentation of yeast mitochondria also occurs [120]. In autophagy, it is
believed that fragmentation of themitochondrial reticulummay occur
to facilitate mitochondrial removal. Mitochondrial fragmentation, in
addition to a possibly role in the path of apoptosis may, in common
with autophagy, facilitate mitochondrial disposal. In fact, mitochon-
drial degradation, shown to be triggered by acetic acid [9], is impaired
in the absence of Dnm1p and, unlike mitochondrial fragmentation
loss of mitochondria seems to mark the commitment point to cell
death [9]. These ﬁndings in yeast may parallel to those in mammalian
cells where mitochondrial fragmentation/destruction appears to play
a crucial role in cell death [121,122].
6. Regulation of yeast mitochondria-dependent apoptosis by
heterologous expression of mammalian proteins
Because of the conservationofmanycellularprocesses inyeast andof
its simple manipulation and genetic tractability, this organism, among
the different cell models exploited to comprehend several mammalian
pathways and processes, emerged as a powerful tool and a model of
choice to answer important biological questions. Yeast lacks obvious
orthologues ofmanykeymammalianapoptotic regulators, including the
Bcl-2 family proteins. However, when many of these proteins are
expressed in yeast, they conserve their functional and molecular effects
at several cellular levels, namely at the mitochondrial level (Fig. 3).
Indeed, the use of these cells has already provided valuable data
concerning the molecular mechanism of action of several apoptotic
proteins, further conﬁrmed in mammalian cells.
In this section we address the effect of mammalian Bcl-2 family
proteins expression in yeast mitochondria and how this study can
contribute to understanding the role of these proteins in mammalian
apoptosis. Moreover, the use of yeast to gain knowledge on the
regulation of mammalian Bcl-2 family proteins by other proteins
involved in mammalian signalling cascades as well as to study several
mitochondria-related human disorders is also discussed.
6.1. Yeast as a tool to study regulation of mitochondria-dependent cell
death by Bcl-2 family proteins
Several studies have examined the response of yeast to the
expression of proteins of the Bcl-2 family, in order to address basic
questions on their mechanisms of action. The idea to use yeast as an
alternative system to study the molecular aspects of the function of
these proteins arose accidentally. The yeast two-hybrid system was
used to test possible interactions between Bcl-2 family members,
namely anti-apoptotic Bcl-2 or Bcl-xL and pro-apoptotic Bax.
Unexpectedly, the chimeric protein LexA-Bax was able to kill yeast,
and death was prevented by the co-expression of native and chimeric
proteins derived from Bcl-2 or Bcl-xL [123]. This ﬁrst report suggested
that these proteins are able to keep at least part of their functionwhen
expressed in a heterologous cellular system devoid of endogenous
homologous proteins [124]. Since then, it was demonstrated that Bcl-2
family members are likely to act upon highly conservedmitochondrial
components in yeast that correspond directly to their apoptotic
Fig. 3. Regulation of yeast mitochondria-dependent apoptosis by heterologous expression of Bcl-2 family proteins. The association of Bax with yeast mitochondria is an essential step
for its action. Recently, the TOM complex has been implicated in Bax insertion, but there is still doubt regarding which component of the TOM complexis involved (see text). tBid has
no effect on Bax insertion in yeast mitochondria but stimulates Bax-induced cyt c release, probably by facilitating its oligomerization. The phospholipid cardiolipin is localized in the
IMM and is involved in cyt c binding to this membrane. Also, it is important for tBid targeting to the OMM and probably interacts with tBid creating unique structures in the contact
sites between the IMM and the OMM. However, this phospholipid is not required for Bax-induced cyt c release. Bax also activates a form of cell death mediated by Uth1p which,
together with cyt c release, is inhibited by Bcl-2 and Bcl-xL.
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biochemical and physiological responses [124–127].
A new research ﬁeld has emergedwhere data, obtained using yeast
as a cell system, provides new information about the function of the
Bcl-2 family proteins. For example, interesting data about functional
interactions among Bax, the anti-apoptotic proteins (Bcl-xL and Bcl-2)
and the pro-apoptotic proteins (Bcl-xS and Bad), were obtained using
yeast cells [128]. It was proposed that Bcl-xS and Bad exert their
activity by binding to anti-apoptotic family members, thereby making
the cell more susceptible to killing by another agent. To test this
hypothesis, an inducible yeast expression system was used to allow
the functional analysis of members of the Bcl-2 family. This study
showed that co-expression of Bcl-xS or Bad with Bcl-xL or Bcl-2 in
yeast did not diminish the ability of the anti-apoptotic members to
antagonize Bax. Rather, co-expression of Bcl-xS potentiates the anti-
death activity of Bcl-xL and Bcl-2. This effect was not the result of
changes in either the levels or integrity of Bax or anti-apoptotic
proteins. Thus, it was possible to conclude that Bcl-xS can bind to anti-
apoptotic family members without inducing loss of biological activity,
and that it may act downstream of Bax in a pathway that is conserved
in yeast [128]. The use of yeast cells also made possible the
identiﬁcation of new mammalian apoptotic regulators, such as Bax
inhibitor-1 (BI-1) [129], bifunctional apoptosis regulator (Bar) [130]
and Calnexin orthologue Cnx1 which acts as an endogenous enhancer
for Bax-induced lethality [131]. Additionally, yeast revealed to be a
valuable tool for the study of Bcl-2 family members insertion in the
mitochondrial membrane [126,132,133].
6.2. Mitochondria in Bax-induced cell death
Bax is essentially a cytosolic protein in mammalian cells with
important functions in mitochondrial morphogenesis [134]. Expres-sion of the pro-apoptotic Bax protein causes growth arrest and cell
death in S. cerevisiae [98,124,126,127,133,135], S. pombe [135,136],
C. albicans [137] and Pichia pastoris [138].
Several reports were published highlighting the role of mitochon-
dria in Bax-induced cell death. Immunoﬂuorescence studies showed
that Bax is closely associated to mitochondria in yeast [139]. Fully
active mitochondria are necessary for Bax lethality since yeast cells
with a “petite” phenotype do not die after Bax expression [133]. The
ability of Bax to kill yeast is higher under respiratory conditions than
under purely fermentative conditions [140]. In fact, it was demon-
strated that oxygen is absolutely required for Bax-induced cell death,
since anaerobic conditions abrogate Bax effect [141]. Mutations
that interfere with oxidative phosphorylation reduce Bax-induced
growth arrest [92]. Moreover, it was shown that mitochondrial F0F1-
ATPase/H+ pump is required for Bax-induced cell death [142]. Ex-
pression of Bax in yeast induces mitochondrial membrane permea-
bilization, cyt c release and ROS production (for a review see
[124,143]). Also arguing for the importance of mitochondria in Bax
effects is the fact that Bax-induced lethality in yeast depends on
mitochondrial lipid oxidation. Bax expression induces oxidation of
mitochondrial lipids and treatments that increase the unsaturation
level of fatty acids, making themmore sensitive to oxidation, increases
the kinetics of Bax-induced cell death [144].
One of the most striking results obtained with heterologous
expression of Bax in yeast was the detection of cyt c release from
mitochondria [90]. Although, this event mimics one of the early steps
of mammalian apoptosis, it is not essential for Bax-mediated cell
killing, since cells lacking cyt c still die after Bax expression, although
at a slower rate [140]. At ﬁrst, it was not known whether this slower
rate was due to an event downstream cyt c release frommitochondria,
abolished due to the absence of cyt c, or because this strain was
respiratory-deﬁcient. But, in a latter report, it was showed that a yeast
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cytoplasm after Bax expression, died at the same rate as a strain
carrying a releasable cyt c [145]. In any case, the detection of cyt c
release in Bax-expressing yeast cells allowed us to recognize yeast as a
powerful tool to study the events regulated by Bax that lead to cyt c
release in mammalian cells.
As mentioned above, cyt c is released after Bax expression, but a
cyt c–GFP is retained [145]. This retention depends on the size of the
fused protein. A histidine (6×His) tag of about 1 kDa did not affect
release of cyt c, however a fusion to the F1-ATPase subunit epsilon of
about 6 kDa prevented it [146]. This dependence on size hinted to the
involvement of a speciﬁc releasemechanism of cyt c. The role of PTP in
Bax-induced cyt c release and cell death was studied by examining the
involvement of putative components of PTP, namely the Por1p, AAC
and cyclophilin. The results obtained were quite contradictory
indicating either a role for Por1p and AAC in Bax effects [147,148] or
showing that Bax is able to induce cyt c release and/or cell death
independently of putative PTP components Por1p, AAC and cyclophi-
lin [91,93,140,149]. Bax has a structural similarity with the pore-
forming domains of bacterial toxins, such as colicins and diphtheria
toxin (reviewed in [150]) and can form channels in synthetic
membranes [151,152]. It was proposed that these channels have the
ability to function as ionic channels, however they were not big
enough to allow the release of cyt c [124]. Pavlov et al. [153]
demonstrated that ion channel activity occurs in the OMM of early
apoptotic mammalian cells and in the mitochondria of yeast cells
expressing Bax. This channel was named mitochondrial apoptosis-
induced channel (MAC) and is a more likely candidate for the release
of cyt c from mitochondria during yeast apoptosis upon Bax
expression. Immunodepletion of MAC activity from lysates of
apoptotic HeLa cells, by Bax antibodies, provided the ﬁrst direct
proof of what was already suspected; that oligomeric Bax was a
component of MAC [154]. This study also showed that Bax and Bak are
functionally redundant with respect to this channel.
Several relevant aspects about the insertion of Bcl-2 family
members, particularly Bax, in the mitochondrial membrane have
been revealed, using yeast cells. The overall fold of Bax is similar to Bcl-
xL andBcl-2. It has 9α-helices, and theone located at the C-terminus of
the protein (α9) corresponds to the transmembrane α-helix of Bcl-2
and Bcl-xL [155]. This transmembrane α-helix is essential for the
insertion of Bcl-2 and Bcl-xL in mitochondria of mammalian cells
[156,157] and to prevent Bax-induced cell death and cyt c release in
yeast cells [133,158,159]. The homology between the C-terminal of Bcl-
2/Bcl-xL and Bax led to the hypothesis that the C-terminal of Bax could
be responsible for Bax targeting and insertion in mitochondria. In fact,
α9 helix of Bax is inserted into the membrane [160]. However, yeast
expression of the human Bax deprived of the C-terminal α-helix
induces the same effects observed with expression of the full length
Bax [91,158]. Moreover, deletion or replacement by a random coiled
sequence of the C-terminalα-helix leads to mitochondrial localization
of this cytosolic protein [126]. Instead, studies with yeast expressing
Bax revealed that the α9 helix is an apoptotic regulation of targeting
(ART) sequence and is important in the interactionwith Bcl-xL [161]. It
has been reported that the N-terminal end of Bax is themitochondrial-
targeting signal in mammalian and yeast cells [132]. Deletion of the
ﬁrst 37 amino acids (BaxΔ1–37) abrogates Bax association to
mitochondria of mammalian cells. Additionally, it was shown that
the sequence corresponding to the ﬁrst α helix (aminoacids 20–37) is
sufﬁcient to induce mitochondrial localization of cytosolic proteins in
mammalian cells, indicating that this sequence is the mitochondrial-
addressing sequence. In yeast, expression of A24R or L26G and L27V
variants of BaxΔ1–19 decreases its cyt c release activity.
TOM22, a component of the translocase of the OMM (TOM), was
identiﬁed as amitochondrial receptor of Bax inmammalian cells [162].
In the same study, yeast TOM22was also found to be required for Bax-
binding to yeast mitochondria. Nevertheless, another report showedthat exposed domains of OMM are not required for tBid/Bax-induced
cyt c release in isolated yeast mitochondria [163]. Ruling out a role
for Tom22p, this study implicates another component of the TOM
complex in this process, the Tom40p. Hence,more studies are required
in order to clarify the role of TOM complex in Bax insertion into
mitochondria.
6.3. Bid and cardiolipin in Bax-induced cell death
Bid is a member of the BH-3-only proteins, a sub-group of the Bcl-2
family whose members are recognised as pro-apoptotic regulators,
acting mainly by interactionwith the anti-apoptotic members of Bcl-2
family proteins [164]. Besides the interaction with anti-apoptotic
members, Bid seems to have other pro-apoptotic functions and yeast
gave new important information about these other effects. Bid is a
cytosolic protein that can be cleaved by caspase 8 to generate a 15 kDa
fragment that corresponds to the C-terminal of Bid, termed truncated
Bid (tBid), and considered the active form of the protein [165,166].
Expression of Bid or tBid in yeast cells has no effect on cell death or cyt
c release. Likewise, no effect was detected with co-expression of these
proteins with the native form of Bax [126]. However, co-expression of
tBid with an active form of Bax enhances cell death and cyt c release,
while co-expression with Bid has no effect [126]. Interestingly, while
Bid has a cytosolic localization in yeast, tBid is found in mitochondria
and its concentration in this organelle increases when co-expressed
with active Bax. The localization of active Bax is not altered by co-
expression with tBid [126]. The effect of tBid in Bax-induced cyt c
release has been attributed to alterations of mitochondrial bioener-
getics after tBid binding to mitochondria [167].
Several reports have discussed the role of cardiolipin in apoptosis
regulation, namely in Bax-mediated cell death. A cardiolipin-less
strain was used to study the role of this lipid in Bax-mediated cyt c
release from mitochondria, showing that cardiolipin is not necessary
for cyt c release [168]. Actually, the absence of this lipid favours Bax-
induced cytochrome c release independently of the presence of tBid
[167]. The absence of tBid effect in Bax action, in a cardiolipin-less
strain, is in agreement with the fact that cardiolipin is implicated in
tBid binding to yeast mitochondria [166]. Yet further studies are
required to understand why the absence of cardiolipin enhances Bax
effects.
As mentioned above, Bax induces mitochondrial lipid oxidation
which affects all lipids, but cardiolipin in more extent [144]. tBid has a
speciﬁcity formetabolites of cardiolipin, speciallymonolysocardiolipin
[169], and induces mitochondrial membrane destabilization [167,169].
The tBid effect on Bax-induced cell death is not due to an interference
with mitochondrial localization of Bax, but occurs after Bax insertion
[126]. This data suggests that tBid, throughout its destabilizing effect
on mitochondrial membrane, may lead to the activation of Bax to its
active ﬁnal conformation, resulting in its oligomerization and, con-
sequently, cell death induction.
6.4. Bax-induced cell death: apoptosis and/or autophagy?
There are several contradictory results regarding the mode of cell
death induced byBaxexpression inyeast. It was shown that expression
of Bax in yeast under the control of a GAL1-10 promoter induces
phosphatidylserine exposure, plasma membrane blebbing, chromatin
condensation and margination, and DNA fragmentation. These
changes are prevented by co-expression with Bcl-xL [170]. More
recently, it was reported that cell death induced by Bax-c-myc,
expressed in yeast under the control of a weaker promoter (tet-off),
induces death without phosphatidylserine exposure or DNA fragmen-
tation [98]. Lack of involvement of Yca1p in Bax-induced cell death has
also been reported [98,125].
Autophagy, a process of intracellular degradation that plays a
crucial role in survival to nutrient starvation might be an alternative
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that this process is involved in Bax-induced cell death in yeast. Yeast
cells expressing Bax-c-myc under the control of a tet-off promoter
display autophagic features like increased accumulation of Atg8p,
uptake of cytosolic material by the vacuole, and the presence of
autophagosomes and autophagic bodies [98]. Uth1p, a protein
required for selective degradation of mitochondria [120] is involved
in Bax-induced yeast cell death. Absence of this protein delays Bax-
induced cell death [173] and switches the death program to a necrotic
one [98]. The ﬁnding that yeast can trigger its suicide by an alternative
cell death programme reinforces a physiological role for yeast cell
death and the conservation of cell death mechanisms in yeast and
mammals.
6.5. The role of Bcl-2 or Bcl-xL and of putative Bcl-2 family yeast
orthologues in mitochondria-dependent apoptosis
Several studies showed that, as observed for animal cells, yeast cell
death induced by the expression of pro-apoptotic Bcl-2 proteins (e.g.,
Bax, Bak, CED-4) can be rescued by the co-expression of the anti-
apoptotic proteins Bcl-2 or Bcl-xL in S. cerevisiae and S. pombe
[123,133,135,136,139,174–178].
It was reported that, similarly to that observed with mammalian
cells undergoingapoptosis, yeast cells expressingBaxexhibit changes in
mitochondrial properties that are inhibited by Bcl-xL through hetero-
dimerization-dependent and -independent mechanisms [179]. This
latter mechanism is associated with the ion channel function of Bcl-xL.
The cytoprotective effect of the anti-apoptotic proteins CED-9, Bcl-
2 and Bcl-xL was also demonstrated in the absence of Bax or any other
pro-apoptotic protein [180]. Indeed, expression of CED-9, Bcl-2 and
Bcl-xL in S. cerevisiae confers resistance to cell death induced by
oxidative stress, such as H2O2, menadione and heat [180]. Another
work showed that expression of human Bcl-xL in S. cerevisiae also
decreases acetic acid-induced yeast cell death, an effect accompanied
by a reduction in DNA degradation and mitochondrial ROS production
[181]. It has also been reported that yeast strains defective in
antioxidant protection, by deletion of the superoxide dismutase
gene, exhibit growth and survival deﬁciencies, which are substantially
improved by Bcl-2 expression [182]. Moreover, under stationary phase
death conditions, yeast cells expressing Bcl-2 [182] or Bcl-xL [25] live
considerably longer than wild-type strains. The protective effect of
Bcl-xL is more prominent in respiratory-competent cells with defects
inmitochondrial ADP/ATP translocation, suggesting amodel for Bcl-xL
regulation of chronological aging at the mitochondria [25].
Mammalian Bcl-2 and Bcl-xL proteins could potentially function
independently of all other yeast proteins to explain their protective
effects in yeast, but it is also possible that some aspects of the
mammalian Bcl-2-dependent pathway are conserved in yeast. Fis1p
of S. cerevisiae is a 18 kDa protein that is anchored to the cytosolic
side of the OMM by a C-terminal hydrophobic-basic domain
characteristic of proteins targeted to the OMM such as Bcl-2 and
Tom5 [108,183]. Fis1p may have Bcl-2-like anti-death activity in
yeast, and several lines of evidence suggest that yeast Fis1p and
human Bcl-2/Bcl-xL act in the same biochemical pathway [9]. The
subcellular localization, topology, and some biophysical properties of
Fis1p are consistent with this possibility. Like Bcl-2/Bcl-xL in
mammals, Fis1p also protects yeast from multiple cell death stimuli
and inhibits the metacaspase-dependent death pathway, but is not
important for growth of cells in the absence of a death stimulus. The
ability of yeast Fis1p to inhibit mitochondrial ﬁssion and degradation
during yeast cell death can be replaced by the human anti-apoptotic
proteins Bcl-2 and Bcl-xL. Indeed, Bcl-xL acts parallel to/downstream
of Fis1p, based on the observation that Bcl-xL inhibits ﬁssion/
fragmentation in ﬁs1Δ (andwild-type) yeast cells, a process mediated
by Dnm1p. However, the possibility that Bcl-2/Bcl-xL inhibits an
additional/alternative parallel pathway cannot be eliminated. Never-theless, the ability of Fis1p, as well as Bcl-2 proteins, to protect yeast
cells from death by inhibiting mitochondrial ﬁssion/destruction
supports and extends the evidence for analogous pathways in
mammalian cells [9].
Another work reported the existence in S. pombe of a protein
containing a group of amino acids with similarity to the Bcl-2 BH-3
death domain, SpRad9 that may represent a member of the Bcl-2
protein family [184]. This study suggests that SpRad9may be amember
of the BH-3-only family of apoptosis promoting proteins. Like human
Rad9, SpRad9 also contains a region near its N-terminus (amino acids
16–30) with similarity to the BH-3 domains of pro-apoptotic Bcl-2
family proteins, but lacks critical residues found inBH-1, BH-2 andBH-4.
Productionof this yeast protein in human cells induces cell death,which
can beblocked by co-expression of Bcl-2 or Bcl-xL. Deletion of the BH-3-
like region fromSpRad9 abolishes its ability to interactwith Bcl-2 and to
induce apoptosis in human cells, consistent with properties of other
members of the BH-3-only pro-apoptotic protein family.
6.6. Speciﬁc modulation of mitochondria-dependent yeast apoptosis and
Bcl-xL cytoprotective effect by distinct mammalian protein kinase C
isoforms
Recently, the idea has emerged that proteins associated to apoptosis
modulation are regulated through phosphorylation by different protein
kinases, such as protein kinase C (PKC). In mammals, PKC is a family of
serine/threonine kinases with at least ten different isoforms grouped
into three sub-families based on their structure and cofactors required
for activation [185]. Regulated by distinct means and presenting
different tissue distribution patterns, PKC isoforms have deserved
particular attention due to their involvement in the regulation of
prominent apoptotic members, such as proteins of the Bcl-2 family
[186,187]. To clarify the role of PKC isoforms in the regulation of Bcl-2
proteins and, consequently, of apoptosis, the yeast S. cerevisiaewasused
in order to carry out an independent analysis of each isoform [181].
Actually, such a goal is difﬁcult to achieve withmammalian cells due to
the co-existence of several PKC isoforms in the same cell. The results
obtained showed that, with the exception of PKC-δ, the PKC isoforms
tested (PKC-α, -ε and -ζ) stimulate S. cerevisiae acetic acid-induced
apoptosis essentially through a mitochondrial ROS-dependent path-
way. Additionally, it was demonstrated, using yeast co-expressing an
individual PKC isoform and the Bcl-xL protein, that PKC isoforms
differently interfere with the cytoprotective effect of Bcl-xL in acetic
acid-induced yeast cell death, by affecting the balance between the
phosphorylated (inactive) or dephosphorylated (active) forms of Bcl-xL.
Co-expression of PKC-α with Bcl-xL completely abolishes the Bcl-xL
anti-apoptotic activity, whereas co-expression of PKC-ε or -ζ with Bcl-
xL causes a marked enhancement of the Bcl-xL anti-apoptotic activity.
Abolishment of the Bcl-xL anti-apoptotic effect by PKC-α co-expression
is accompanied by a pronounced decrease of the Bcl-xL depho-
sphorylated form, and the remarkable increase in the Bcl-xL anti-
apoptotic effect by PKC-ε or -ζ co-expression is accompanied by a
pronounced decrease of the Bcl-xL phosphorylated form. By contrast,
PKC-δ practically has no effect on Bcl-xL phosphorylated state. In fact,
PKC-α -ε or -ζ, which elicits a pronounced stimulation ofmitochondrial
ROS production, also interferes markedly with the mitochondrial anti-
apoptotic protein Bcl-xL. Consistently, PKC-δ, which only causes a slight
stimulation of mitochondrial ROS production, displays a reduced effect
on this mitochondrial protein [181]. These results corroborate the
interpretation that the different inﬂuences ofmammalian PKC isoforms
on apoptosis can be due to distinctmodulation of apoptoticmembers of
the Bcl-2 family by each isoform.
6.7. Yeast models of human mitochondrial diseases
In recent years, yeast has revealed to be a powerful model to
identify responsible genes, to study primary effects of pathogenic
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mitochondrial disorders [188].
Mitochondria-dependent yeast apoptosis has been used in the
resolution of other questions, such as the elucidation of the apop-
togenic mode of action of the Vpr encoded by HIV-1 [85]. Based on the
evidence obtained with experimental systems, namely with yeast
strains lacking AAC or VDAC, it was demonstrated that Vpr induces
apoptosis via a direct effect on the mitochondrial PTP complex.
Consequently, yeast cells lacking putative proteins of the PTP complex
become relatively resistant to the cytotoxic effect of Vpr. Thus, Vpr
represents a novel type of viral peptide that can interact with the PTP
complex to permeabilize mitochondrial membranes and trigger the
apoptotic program.
Mitochondrial yeast apoptosis has been also extensively explored
to study themechanisms and pathways ofmammalianproteins crucial
for neurodegenerative disorders [189]. In particular, yeast cells
revealed to be a valuable model of Parkinson's disease [190–192].
While it has been shown that mutant forms of synuclein may form
inclusion bodies (IB) and cause apoptotic death of neurons in humans
(reviewed in [193]), the mechanism of the disease development is
largely unknown. To study this mechanism, the mutant forms of the
proteinwere expressed inyeast and the formationof IB followedbycell
deathwere observed. Importantly, similar to neuronal death, the death
of yeast is accompanied by the appearance of apoptotic markers [190].
In fact, it was demonstrated that heterologous expression of humanα-
synuclein in S. cerevisiae triggers apoptotic markers in yeast, such as
loss of membrane asymmetry due to the externalization of phospha-
tidylserine, ROS production and the release of cyt c frommitochondria.
Moreover, it was found that application of a brief heat shock prevents
α-synuclein-induced apoptosis, suggesting an important role of the
heat shock response during neurodegenerative disorders. It was also
shown that α-synuclein interferes with proteasome composition and
impairs proteasome-mediated protein degradation, protein synthesis,
and the ability to maintain survival during yeast stationary phase.
Together these evidence suggested the involvement of the protea-
some/Cdc48p/mitochondria apoptotic axis in the of α-synuclein
apoptotic pathway [190].
Another example of a yeast-based model of neuronal pathology is
expression of expanded polyglutamine (polyQ) fragment of huntingtin
(Htt1). The mutant form of Htt1 causes hereditary neuronal
degeneration in humans that is accompanied by polyQ-mediated
aggregation of Htt1 and accumulation of apoptotic markers in the
affected neurons [194]. When expressed in yeast, the polyQ-fragment
also forms IBs and induces cell death [195,196]. In a recent work, it was
shown that expression of an expanded polyQ domain in yeast has
physiological consequences similar to those observed in neurons,
triggering cell death accompanied by a set of apoptosis-linked changes
in mitochondria, metacaspase activation and nuclear DNA fragmenta-
tion [197]. These data demonstrate that yeast expressing polyQ
represents a valuable model of Huntington's disease.
7. Conclusions and future perspectives
Mitochondria are important organelles of the apoptotic machinery
in mammalian cells and several reports suggest that the ﬁnal decision
of life or deathmay residewithin or depend on these organelles. There
is now a wealth of evidence suggesting that mitochondria are equally
important for apoptosis in the unicellular yeast S. cerevisiae.
In this review we attempted to organize what is currently known
about the yeast apoptotic process in connection with mitochondria.
Although considerable work has been made describing the participa-
tion of mitochondria in cell death execution, the role of most
mitochondrial proteins engaged in the apoptotic process, as well as
the regulation of the mitochondria-mediated pathway, is still poorly
understood. These aspects include among others the upstream and
downstream signalling of mitochondrial cascades. Speciﬁcally, someuncovered issues relate to: i) whether there is a single mechanism of
MOMP mediating the release of cyt c, Aif1p and Nuc1p, or if there are
speciﬁc mechanisms for each protein; ii) the putative involvement of
proteases other than the yeast metacaspase acting upstream or
downstream mitochondria; iii) downstream effects of cyt c and how
its release is connected to mitochondrial network fragmentation; iv)
whether mitochondrial apoptotic regulators act through the same or
separate pathways.
The model organism S. cerevisiae may prove particularly useful to
answer these questions and to provide a step forward in the under-
standing of mitochondria-linked apoptosis.
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